Financhill
Back

ACADIA Pharmaceuticals Vs. Regulus Therapeutics Industry Stock Comparison

Sell
30

ACAD
ACADIA Pharmaceuticals

Last Price:
15.25
Seasonality Move:
7.01%
Sell
36

RGLS
Regulus Therapeutics

Last Price:
2.21
Seasonality Move:
-15.53%
Sell
30
ACADIA Pharmaceuticals (ACAD) is a Sell

Is ACADIA Pharmaceuticals a Buy, Sell or Hold?

  • The current ACADIA Pharmaceuticals [ACAD] share price is $15.25. The Score for ACAD is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Regulus Therapeutics (RGLS) is a Sell

Is Regulus Therapeutics a Buy, Sell or Hold?

  • The current Regulus Therapeutics [RGLS] share price is $2.21. The Score for RGLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • RGLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACAD Stock Price Chart

What is ACADIA Pharmaceuticals's stock price today?

  • The ACADIA Pharmaceuticals share price today is $15.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.

RGLS Stock Price Chart

What is Regulus Therapeutics's stock price today?

  • The Regulus Therapeutics share price today is $2.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLS is experiencing slight selling pressure.

ACAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.66 Sell
Relative Strength Index (14 RSI): 27.51 Sell
Chaikin Money Flow: -769952 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.31 - 17.57) Sell
Bollinger Bands (100): (17.89 - 28.11) Sell

RGLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 43.85 Sell
Chaikin Money Flow: -156913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.22 - 2.66) Sell
Bollinger Bands (100): (1.26 - 2.44) Buy

ACAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.63 Sell
20-day SMA: 16.76 Sell
50-day SMA: 18.43 Sell
200-day SMA: 23.81 Sell
8-day EMA: 16.33 Sell
20-day EMA: 16.88 Sell
50-day EMA: 18.67 Sell
200-day EMA: 22.17 Sell

RGLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.4 Sell
20-day SMA: 2.37 Sell
50-day SMA: 2.36 Sell
200-day SMA: 1.62 Buy
8-day EMA: 2.32 Sell
20-day EMA: 2.38 Sell
50-day EMA: 2.27 Sell
200-day EMA: 1.79 Buy

ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.55 per share.

Regulus Therapeutics Earnings Growth & RGLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.06 per share, and a decrease next year of $0.02 per share.

ACADIA Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regulus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):